Tenley Archer

Affiliations: 
2020- Algen Biotechnologies 
Google:
"Tenley Archer"
Mean distance: 15.51 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Maynard R, Poore B, Hanaford AR, et al. (2021) TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters
Archer TC, Ehrenberger T, Mundt F, et al. (2018) Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 34: 396-410.e8
Waszak SM, Northcott PA, Buchhalter I, et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. The Lancet. Oncology
Archer TC, Sengupta S, Pomeroy SL. (2018) Brain cancer genomics and epigenomics. Handbook of Clinical Neurology. 148: 785-797
Archer TC, Mahoney EL, Pomeroy SL. (2017) Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
Boulay G, Awad ME, Riggi N, et al. (2017) OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Cancer Discovery
Wang X, Lee RS, Alver BH, et al. (2016) SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Nature Genetics
Hanaford AR, Archer TC, Price A, et al. (2016) DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Hanaford A, Archer T, Price A, et al. (2016) MB-103DiSCoVERing INNOVATIVE THERAPIES: COMBINING GENETICALLY ACCURATE DISEASE MODELS OF MEDULLOBLASTOMA WITH ADVANCED IN SILICO ANALYSIS TO IDENTIFY NOVEL THERAPEUTIC TARGETS Neuro-Oncology. 18: iii120.3-iii120
Archer TC, Pomeroy SL. (2015) Defining the molecular landscape of ependymomas. Cancer Cell. 27: 613-5
See more...